Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Neurology|June 5, 2021
Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal TumorsGiulia Berzero, Luisa Bellu, Capucine Baldini, et al.
The Lancet Regional Health. Europe|February 3, 2025
Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort studyLotta Plomp, Hortense Chassepot, Dimitri Psimaras, et al.
Journal for Immunotherapy of Cancer|December 5, 2019
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive studyGuillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, et al.
American Journal of Hematology|April 8, 2024
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC networkSylvain Choquet, Carole Soussain, Nabih Azar, et al.
Journal of the Peripheral Nervous System : JPNS|May 13, 2014
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS studyKathleen A Griffith, Susan G Dorsey, Cynthia L Renn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 24, 2024
Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABABR AntibodiesFlorian Lamblin, Jeroen Kerstens, Sergio Muñiz-Castrillo, et al.
Nature Medicine|December 12, 2018
The molecular landscape of glioma in patients with Neurofibromatosis 1Fulvio D'Angelo, Michele Ceccarelli, Tala, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 17